Showing results (1951-1960 of 2,694) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|April 11, 2022
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID StudyCristina Menni, Anna May, Lorenzo Polidori, et al.
The Lancet. Infectious Diseases|July 9, 2022
Outbreak of sexually transmitted, extensively drug-resistant Shigella sonnei in the UK, 2021-22: a descriptive epidemiological studyHannah Charles, Mateo Prochazka, Katie Thorley, et al.
The Lancet. Infectious Diseases|April 24, 2022
Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trialNicolas Folschweiller, Carline Vanden Abeele, Laurence Chu, et al.
The Lancet. Infectious Diseases|May 6, 2023
Infectious diseases in Indigenous populations in North America: learning from the past to create a more equitable futureNaomi R Lee, Alexandra King, Deionna Vigil, et al.
The Lancet. Infectious Diseases|May 7, 2023
Lessons from COVID-19 for rescalable data collectionSangeeta Bhatia, Natsuko Imai, Oliver J Watson, et al.
The Lancet. Infectious Diseases|May 1, 2023
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trialDerick Kimathi, Aitana Juan-Giner, Benedict Orindi, et al.
The Lancet. Infectious Diseases|March 27, 2021
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trialsShilong Yang, Yan Li, Lianpan Dai, et al.
The Lancet. Infectious Diseases|April 3, 2021
Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling studyPeter C Jentsch, Madhur Anand, Chris T Bauch
The Lancet. Infectious Diseases|April 9, 2021
New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trialFaustino Torrico, Joaquim Gascón, Fabiana Barreira, et al.
The Lancet. Infectious Diseases|March 31, 2023
Economic evaluations of interventions to prevent and control health-care-associated infections: a systematic reviewStephen Rice, Katherine Carr, Pauline Sobiesuo, et al.
Pageof 270